Skip to content

Prime Medicine PRME Compensation and benefits

Compensation and benefits at other companies

Eli Lilly logo
Eli LillyLLY
Sana Biotechnology logo
Sana BiotechnologySANA
Opus Genetics logo
Opus GeneticsIRD
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
Precigen logo
PrecigenPGEN
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's compensation and benefits?
Prime Medicine (PRME) reported compensation and benefits of $2.19M in Q1 2026.
How has Prime Medicine's compensation and benefits changed year-over-year?
Prime Medicine's compensation and benefits decreased by 47.6% year-over-year, from $4.18M to $2.19M.
What is the long-term trend for Prime Medicine's compensation and benefits?
Over 4 years (2021 to 2025), Prime Medicine's compensation and benefits has grown at a 32.7% compound annual growth rate (CAGR), from $2.36M to $7.34M.